400
Participants
Start Date
June 24, 2021
Primary Completion Date
August 7, 2024
Study Completion Date
August 7, 2024
Inclisiran
Inclisiran sodium 300 mg / 1.5 ml (equivalent to 284 mg of inclisiran)
Northwell Health, Manhasset
Jamaica Hospital Medical Center, Jamaica
Laurelton Heart Specialist PC, Rosedale
Capital Cardiology Associates, Albany
Bassett Medical Center, Cooperstown
University At Buffalo, Buffalo
Allegheny General Hospital, Pittsburgh
University of Pittsburgh Medical Center HABOT, Erie
Lancaster General Health, Lancaster
Guthrie Clinic, Sayre
Washington Hospital Center, Washington D.C.
George Washington Univ Medical Ctr, Washington D.C.
Tidal Health Peninsula Regional Inc, Salisbury
Selma Medical Associates, Winchester
Dominion Medical Associates, Richmond
York Clinical Research, Norfolk
TPMG Clinical Research, Newport News
Carilion Clinic, Roanoke
Wake Forest University Baptist Medical Center, Winston-Salem
Moses Cone Hospital-Lebauer CV Research Foundation, Greensboro
Cary Research Group, Cary
Pinehurst Medical Clinic, Pinehurst
Clinical Trials Of America LLC, Lenoir
Morehouse School Of Medicine, Atlanta
Emory University, Atlanta
Ellipsis Group, Atlanta
Northside Hospital, Atlanta
Cardiology Research Associates, Daytona Beach
Baptist Health Research Institute, Jacksonville
Cardiology Consultants, Pensacola
Inpatient Research Clinical LLC, Miami Lakes
Innovation Medical Group LLC, Palmetto Bay
Reliant Medical Research, Miami
Holy Cross Hospital Inc, Fort Lauderdale
Teradan Clinical trials LLC, Brandon
Theia Clinical Research Ctrs LLC, Tampa
Clearwater Cardiovascular and Interventional Consultants, Clearwater
Nova Clinical Research LLC, Bradenton
Covenant Medical Group, Knoxville
Cardiology Associates of North MS, Tupelo
Jackson Heart Clinic, Jackson
University of Toledo, Toledo
Aultman Hospital, Canton
Franciscan Health Services Research Center, Indianapolis
Cardiovascular Research Of Northwest Indiana, Llc, Munster
Trinity Health Michigan Heart, Ypsilanti
St Marys of Ascension Research, Saginaw
MidMichigan Physicians Group, Midland
Sparrow Clincal Research Institute, Lansing
Iowa Heart Center, Des Moines
Minneapolis Heart Institute, Minneapolis
CentraCare Heart and Vascular Center, Saint Cloud
Monument Health Clinical Research, Rapid City
Northwest Heart Clinical Rsrch LLC, Arlington Heights
AMITA Heart and Vascular Group, Hinsdale
St Louis Heart and Vascular, St Louis
Midwest Heart and Vascular Spec, Overland Park
Bryan LGH Heart Inst Intigrated Cardiology Group, Lincoln
Meridian Clinical Research, Lincoln
Northeast Arkansas Baptist Clinic, Jonesboro
St John Health System, Bartlesville
CardioVoyage LLC, McKinney
Research Group of North Texas, Sunnyvale
Baylor Scott and White Heart and Vascular Hospital, Dallas
Tyler Cardiovascular Consultants, Tyler
The Heart Institute of East Texas, Lufkin
Vilo Research Group LLC, Houston
Texas Heart Medical Group, Houston
UT Physicians Memorial Hermann, Houston
Northwest Houston Cardiology PA, Houston
West Houston Area Clinical Trial Consultants, Houston
Aurora Denver Cardiology Associates, Aurora
Colorado Heart and Vascular, Lakewood
Colorado Springs Cardiology, Colorado Springs
Intermountain Medical Center, Murray
Clinnova Research Solutions, Torrance
Harbor-UCLA Medical Center, Torrance
Interv Cardiology Med Grp, West Hills
Mission Heritage Medical Group, Mission Viejo
Central Cardiology Medical Center, Bakersfield
The Heart Group Cardiovascular Associates Inc, Fresno
Northbay Clinical Research LLC, Santa Rosa
Bend Memorial Clinic, Bend
MultiCare Institute for Research and Innovation, Tacoma
Cardiology Ass of Fairfield County, Stamford
Advanced Heart Care, LLC, Bridgewater
Cardiovas Assoc of Delaware Valley, Elmer
Inspira Medical Cent Mullica Hill, Mullica Hill
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY